Journal profile · Pharmacology & Pharmacy
Biomolecules & Therapeutics
ISSN 1976-9148 · eISSN 2005-4483 · Korean Society of Applied Pharmacology · SOUTH KOREA · Quarterly · Founded 2008
Biomolecules & Therapeutics: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 4.88; subscription journal; median 88 days to acceptance (83 articles, last 24 months); community-reported acceptance: easy; 95 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Biomolecules & Therapeutics is published by Korean Society of Applied Pharmacology and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmacological Effects of Natural Compounds, Natural product bioactivities and synthesis and Neuroscience and Neuropharmacology Research, together about 20.7% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Biomolecules & Therapeutics (Biomolecules & Therapeutics) (Print ISSN 1976-9148, Online ISSN 2005-4483) is an international, peer-reviewed, open access journal that covers pharmacological and toxicological fields related to bioactive molecules and therapeutics. It was launched in 1993 as "The Journal of Applied Pharmacology (ISSN 1225-6110)", and renamed "Biomolecules & Therapeutics" (Biomol Ther: abbreviated form) in 2008 (Volume 16, No. 1). It is published bimonthly in January, March, May, July, September and November. All manuscripts should be creative, informative, and contribute to the development of new drugs. Articles in the following categories are published: review articles and research articles.
Source: LetPub
Research area (LetPub): Pharmacology & Pharmacy
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmacological Effects of Natural CompoundsPharmacology, Toxicology and Pharmaceutics7.6%
- Natural product bioactivities and synthesisBiochemistry, Genetics and Molecular Biology7%
- Neuroscience and Neuropharmacology ResearchNeuroscience6.1%
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology5.6%
- Genomics, phytochemicals, and oxidative stressBiochemistry, Genetics and Molecular Biology5.5%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience5.2%
- Food Quality and Safety StudiesAgricultural and Biological Sciences5.2%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.88LetPub ·
- CiteScore 2026-06
- 6.4LetPub ·
- SJR 2026-06
- 0.97LetPub ·
- SNIP 2026-06
- 1LetPub ·
- h-index
- 26LetPub ·
- h-index
- 71OpenAlex ·
- i10-index
- 803OpenAlex ·
- 2-year mean citedness
- 3.83OpenAlex ·
- Self-citation rate
- 14.3%LetPub ·
- Share of gold OA articles
- 98.69%LetPub ·
Volume
- Articles per year
- 91LetPub ·
Articles by year OpenAlex count · 1,957 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 73 | 73 | 28 |
| 2025 | 95 | 95 | 275 |
| 2024 | 85 | 85 | 666 |
| 2023 | 67 | 67 | 957 |
| 2022 | 69 | 69 | 762 |
| 2021 | 76 | 76 | 1,617 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
88 daysMedian, submission to acceptance · P25–P75 44 days – 126 days
- Acceptance to online
- median 41 days (83 articles)
- Submission to online
- median 141 days
- Sample
- 83 articles with submission and acceptance dates (202 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Korean Society of Applied Pharmacology
- Country or region
- SOUTH KOREA
- Language
- English
- Frequency
- Quarterly
- Founded
- 2008
- ISSN
- 1976-9148
- Electronic ISSN
- 2005-4483
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Biomolecules & Therapeutics
What CAS zone is Biomolecules & Therapeutics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Biomolecules & Therapeutics is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Biomolecules & Therapeutics?
The latest impact factor listed by LetPub is 4.88; CiteScore 6.4, h-index 71.
How long does peer review take at Biomolecules & Therapeutics?
Based on the dates recorded on 83 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 88 days (interquartile range 44–126 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Biomolecules & Therapeutics?
According to LetPub and DOAJ records, Biomolecules & Therapeutics is indexed in SCIE and Scopus.
Is Biomolecules & Therapeutics open access, and what is the APC?
Biomolecules & Therapeutics is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .